Sanofi extends offer for outstanding Genzyme shares
PARIS |
PARIS (Reuters) - French drugmaker Sanofi-Aventis (SASY.PA) has extended its offer for all outstanding shares of U.S. biotech Genzyme GENZ.O until April 1 from March 16, it said in a statement on Monday.
"Sanofi-Aventis announced today that in accordance with its definitive merger agreement with Genzyme Corp, it has revised its outstanding offer to become an offer to exchange all outstanding shares of common stock of Genzyme for $74.00 in cash without interest and less any required withholding taxes and one contingent value right, per share," Sanofi said.
(Reporting by James Regan; Editing by Blaise Robinson)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints


Follow Reuters